Dr. Hosseinipour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27599Phone+1 919-966-4996Fax+1 919-843-5515
Education & Training
- University of North Carolina HospitalsFellowship, Infectious Disease, 1999 - 2002
- Baylor College of MedicineResidency, Internal Medicine, 1995 - 1998
- Northwestern University The Feinberg School of MedicineClass of 1995
Certifications & Licensure
- NC State Medical License 1999 - 2025
- GA State Medical License 1998 - 1999
- TX State Medical License 1996 - 1999
- WA State Medical License 1998 - 1999
- WI State Medical License 1998 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma Start of enrollment: 2011 Nov 18
- REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment Start of enrollment: 2011 Oct 01
- HIV Diagnosis in Hospitalized Malawian Infants Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.Jessica M Fogel, Deborah Persaud, Estelle Piwowar-Manning, Paul Richardson, Joseph Szewczyk
AIDS Research and Human Retroviruses. 2024-10-28 - 2 citationsFeatures of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.Raphael J Landovitz, Sinead Delany-Moretlwe, Jessica M Fogel, Mark A Marzinke, Estelle Piwowar-Manning
The New England Journal of Medicine. 2024-10-03 - Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial.Nigel Garrett, One Dintwe, Cynthia L Monaco, Megan Jones, Kelly E Seaton
Journal of Acquired Immune Deficiency Syndromes. 2024-08-01
Journal Articles
- HIV-1 Transmission Among Persons with Acute HIV-1 Infection in Malawi: Demographic, Behavioral and Phylogenetic RelationshipsMina C Hosseinipour, Sarah E Rutstein, Myron S Cohen, Clinical Infectious Diseases
- Oa Global Health Mentoring Toolkits: A Scoping Review Relevant for Low- and Middle-Income Country InstitutionsMina C Hosseinipour, Bhakti Hansoti, The American Journal of Tropical Medicine and Hygiene
- HIV Associated Neurocognitive Impairment in Diverse Resource Limited SettingsChristina M Marra, Mina C Hosseinipour, Clinical Infectious Diseases
Press Mentions
- Long-Lasting Shots Work Better Than Daily Pills to Prevent HIV in at-Risk WomenNovember 30th, 2020
- Africa: HIV Prevention Injection Hailed as a ‘Major Breakthrough’ for WomenNovember 11th, 2020
- NIH Launches HIV Prevention Trial of Long-Acting Injectable Medication in Sexually Active WomenNovember 30th, 2017
- Join now to see all
Grant Support
- Effect Of Parasitic Infection Of HIV Diseaes In MalawiFogarty International Center2004–2006
- Effect Of Parasitic Infection Of HIV Diseases In MalawiFogarty International Center2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: